Philip Philip, MD of Karmanos Cancer Institute gives his take on the use of capecitabine in biliary cancers at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Use of capecitabine in biliary cancers
Philip Philip, MD of Karmanos Cancer Institute gives his take on the use of capecitabine in biliary cancers at the 2017 Annual Meeting Annual Meeting in Chicago, IL.